|
|
|||
|
||||
OverviewOur understanding of the scientific basis for urothelial malignancy has advanced significantly. Studies in prostate cancer, few and far between 20 years ago, have increased and the degree of Government intervention, both in Europe and America, to support work in this field has risen considerably. Interest too has grown from the pharmaceutical industry, and this has led to the development of new treatment options for all of the urological malignancies and real improvements in remission rates and durations.This book outlines developments in all areas of urological cancer, bringing together summaries of clinical and molecular advances in one volume, which will be invaluable to urologists and oncologists. Full Product DetailsAuthor: Jonathan WaxmanPublisher: Springer London Ltd Imprint: Springer London Ltd Edition: 2005 ed. Dimensions: Width: 17.80cm , Height: 2.30cm , Length: 25.40cm Weight: 0.956kg ISBN: 9781852339111ISBN 10: 185233911 Pages: 342 Publication Date: 18 August 2005 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsFrom the reviews: <p> This is an impressive text set out in such a manner that the major malignancies of urological cancers are sequential. a ] The format is user friendly and allows the reader to find specific information in an ordered fashion. a ] The conclusion of each chapter is succinct and informative a ] . Useful tables in an easily readable format are contained through the text a ] . this is an informative and clinically up-to-date text, which should appeal to medical staff, the urological nursing group a ] . (Mary Leahy, CancerForum, Vol. 30 (3), November, 2006) Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||